Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

GeneNews closes concurrent private placement offerings for US$2.1 million

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

GeneNews Limited

On November 12, 2010, GeneNews Limited (TSX:GEN) completed its two previously announced concurrent private placement offerings: one offering of units and another offering of five-year senior 15% redeemable convertible secured debentures. Through the concurrent offerings, GeneNews raised total gross proceeds of $2,125,452. GeneNews is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management based on disease-specific biomarkers. GeneNews was advised in this transaction by Fasken Martineau with a team that included Geoff Clarke, Brad Freelan, and Michael Shour (corporate/securities).

Team

    Subscribe

    Receive email updates from our team

    Subscribe